Search results for "GLP-1"

The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications, have been found to significantly...
Daegu’s APAAC 2026 Opens With Expanded Focus on Healthspan Beyond Cosmetic Anti-Aging

Daegu’s APAAC 2026 Opens With Expanded Focus on Healthspan Beyond Cosmetic Anti-Aging

The 9th Asia Pacific Anti-Aging Conference (APAAC 2026), one of Daegu’s flagship international medical events, will run for three days from Nov.
“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

The first domestically developed obesity medication is entering South Korea’s weight-loss market, long dominated by...

"My Cancer Treatment Is Over, but I Keep Gaining Weight": 6 in 10 Post-Surgery Patients Struggle With Weight Management

For patients returning to daily life following cancer treatment, managing body weight presents a secondary, formidable...
Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch

Daewoong Pharmaceutical to Build Aseptic Manufacturing Facility for Semaglutide Microneedle Patch

Daewoong Pharmaceutical is accelerating efforts to secure Good Manufacturing Practice approval and establish an...
Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul

Lexraza Developer and Lilly Obesity Chief to Headline Global Clinical Trial Summit in Seoul

What will it take to build on the success of Lexraza, South Korea’s landmark lung cancer drug, and propel it into the...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
Endocrinologist Woo Chang-yoon Touts ‘Natural Wegovy’ Egg and Olive Oil Combo to Tame Cravings

Endocrinologist Woo Chang-yoon Touts ‘Natural Wegovy’ Egg and Olive Oil Combo to Tame Cravings

Woo Chang-yoon, an endocrinologist who has emerged as a prominent voice behind the “natural Wegovy” diet trend, has...
Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical and AUL Bio Seek Phase 1 Approval for Once-Monthly Obesity Drug AUL009

Kyungdong Pharmaceutical announced Sept. 2 that it has submitted an investigational new drug application to the...
Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Hanmi Pharmaceutical Nears Korean Launch for Obesity Drug EPPE After Five-Year Detour

Licensed out to French pharmaceutical giant Sanofi in 2015 and returned five years later, Hanmi Pharmaceutical’s...